Perceptive Advisors Llc Buys PROCEPT BioRobotics Corp, Icosavax Inc, IVERIC bio Inc, Sells Nevro Corp, United Therapeutics Corp, Kadmon Holdings Inc

• New Purchases: PRCT, ICVX, SLGC, HLTH, SMFR, IMRX, NTRA, TYRA, ABSI, NUVL, BIIB, PODD, KYMR, PNT, CCXI, SGHT, RPID, DALS, SRZN, IMGO,
• Added Positions: ISEE, MRTX, FOLD, KOD, CERE, RAPT, IOVA, VRDN, INBX, GBT, ATXS, XENE, BCAB, TVTX, HCAT, CHRS, ACCD, ONEM, CMAX,
• Reduced Positions: NVRO, UTHR, NBIX, AXSM, ZY, NVTA, ZYME, ATEC, OM, RCKT, ESTA, PMVP, VYNE, CLDX, ADMA, ONCR, DAWN, RNA, FUSN, NEPT, MORF, KRON, HZNP, RLAY, APLS, ACRS,
• Sold Out: KDMN, MDT, DRNA, NARI, EXAS, XLRN, ARWR, RGEN, COLL, STOK, FBRX, CMIIU, RACA, CVRX, CTMX, SILK, PRVA, MREO, AKYA, CHFW.U, BCTG, LGV.U, AMWL, CMLF, MRUS, GRTX, SRRA, SGTX, PLXP, TCRR, TKNO,

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/perceptive+advisors+llc/current-portfolio/portfolio

1. Mirati Therapeutics Inc (MRTX) - 3,387,745 shares, 9.88% of the total portfolio. Shares added by 6.34%
2. BridgeBio Pharma Inc (BBIO) - 7,756,928 shares, 6.00% of the total portfolio.
3. SpringWorks Therapeutics Inc (SWTX) - 4,849,912 shares, 5.07% of the total portfolio.
4. Iovance Biotherapeutics Inc (IOVA) - 11,489,772 shares, 4.67% of the total portfolio. Shares added by 4.84%
5. Amicus Therapeutics Inc (FOLD) - 26,559,443 shares, 4.18% of the total portfolio. Shares added by 14.87%

Perceptive Advisors Llc initiated holding in PROCEPT BioRobotics Corp. The purchase prices were between $35.91 and $41.94, with an estimated average price of $38.38. The stock is now traded at around $43.510000. The impact to a portfolio due to this purchase was 1.04%. The holding were 1,656,990 shares as of 2021-09-30.

Perceptive Advisors Llc initiated holding in Icosavax Inc. The purchase prices were between $24.85 and $40.25, with an estimated average price of $34.02. The stock is now traded at around $26.790000. The impact to a portfolio due to this purchase was 0.94%. The holding were 1,922,549 shares as of 2021-09-30.

Perceptive Advisors Llc initiated holding in SomaLogic Inc. The purchase prices were between $10.2 and $12.77, with an estimated average price of $11.41. The stock is now traded at around $13.720000. The impact to a portfolio due to this purchase was 0.42%. The holding were 2,050,000 shares as of 2021-09-30.

Perceptive Advisors Llc initiated holding in Cue Health Inc. The purchase prices were between $11.81 and $20, with an estimated average price of $15.75. The stock is now traded at around $13.140000. The impact to a portfolio due to this purchase was 0.31%. The holding were 1,580,607 shares as of 2021-09-30.

Perceptive Advisors Llc initiated holding in Sema4 Holdings Corp. The purchase prices were between $0 and $12.25, with an estimated average price of $9.55. The stock is now traded at around $7.290000. The impact to a portfolio due to this purchase was 0.31%. The holding were 2,500,000 shares as of 2021-09-30.

Perceptive Advisors Llc initiated holding in Immuneering Corp. The purchase prices were between $17 and $32.84, with an estimated average price of $26.9. The stock is now traded at around $27.650000. The impact to a portfolio due to this purchase was 0.3%. The holding were 681,051 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in IVERIC bio Inc by 62.94%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.480000. The impact to a portfolio due to this purchase was 0.77%. The holding were 7,471,798 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in Kodiak Sciences Inc by 61.25%. The purchase prices were between $81.97 and $106.94, with an estimated average price of $92.46. The stock is now traded at around $107.960000. The impact to a portfolio due to this purchase was 0.28%. The holding were 461,248 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in Viridian Therapeutics Inc by 79.11%. The purchase prices were between $10.69 and $18.2, with an estimated average price of $14.67. The stock is now traded at around $18.780000. The impact to a portfolio due to this purchase was 0.17%. The holding were 1,423,000 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in Inhibrx Inc by 23.64%. The purchase prices were between $25.18 and $37.81, with an estimated average price of $30.45. The stock is now traded at around $43.940000. The impact to a portfolio due to this purchase was 0.12%. The holding were 1,121,490 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in Astria Therapeutics Inc by 52.95%. The purchase prices were between $7.32 and $12.9, with an estimated average price of $9.62. The stock is now traded at around $6.920000. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,959,652 shares as of 2021-09-30.

Perceptive Advisors Llc added to a holding in Xenon Pharmaceuticals Inc by 20.43%. The purchase prices were between $14.86 and $19.45, with an estimated average price of $17.41. The stock is now traded at around $31.990000. The impact to a portfolio due to this purchase was 0.09%. The holding were 2,022,051 shares as of 2021-09-30.

Perceptive Advisors Llc sold out a holding in Kadmon Holdings Inc. The sale prices were between $3.55 and $9.09, with an estimated average price of $5.66.

Perceptive Advisors Llc sold out a holding in Medtronic PLC. The sale prices were between $122.75 and $135.17, with an estimated average price of $129.47.

Perceptive Advisors Llc sold out a holding in Dicerna Pharmaceuticals Inc. The sale prices were between $19.68 and $39.99, with an estimated average price of $27.67.

Perceptive Advisors Llc sold out a holding in Inari Medical Inc. The sale prices were between $71.29 and $95.99, with an estimated average price of $84.14.

Perceptive Advisors Llc sold out a holding in Exact Sciences Corp. The sale prices were between $90.24 and $124.05, with an estimated average price of $105.88.

Perceptive Advisors Llc sold out a holding in Acceleron Pharma Inc. The sale prices were between $115.25 and $182.78, with an estimated average price of $130.74.